Increased midtrimester amniotic fluid activin A

A risk factor for subsequent fetal death

F. Petraglia, R. Gomez, S. Luisi, P. Florio, Jorge Tolosa, M. Stomati, R. Romero

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

OBJECTIVE: The objective of this study was to determine whether concentrations of activin A and corticotropin-releasing factor in amniotic fluid can identify patients at risk of fetal death. STUDY DESIGN: A retrospective case-control study of women who have had a midtrimester amniocentesis was designed. Case subjects consisted of patients who had a spontaneous fetal death after the procedure, whereas the control group consisted of patients who had a normal pregnancy outcome after midtrimester amniocentesis. Dimeric activin A was measured by a specific 2-site enzyme immunoassay, and corticotropin-releasing factor was measured by a specific and sensitive radioimmunoassay after acidic extraction. Statistical analysis was performed with Mann-Whitney U test, Fisher's exact test, and χ2 tests and regression analysis. RESULTS: First, activin A was detectable in all amniotic fluid samples. Second, the concentration of activin A in amniotic fluid increased with advancing gestational age. Third, patients who subsequently had a fetal death had a higher median concentration of activin A than those with a normal pregnancy outcome (P <.01). Fourth, an amniotic fluid concentration of activin A greater than the 95th confidence interval for gestational age was found in 40% of patients who subsequently had a fetal death (odds ratio: 21.6; P <.005). Finally, the median concentration of corticotropin-releasing factor in amniotic fluid was not different in case subjects and control subjects. CONCLUSIONS: An elevated concentration of activin A in amniotic fluid identifies women at risk of fetal death.

Original languageEnglish (US)
Pages (from-to)194-197
Number of pages4
JournalAmerican Journal of Obstetrics and Gynecology
Volume180
Issue number1 I
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Fetal Death
Second Pregnancy Trimester
Amniotic Fluid
Corticotropin-Releasing Hormone
Amniocentesis
Pregnancy Outcome
Gestational Age
Nonparametric Statistics
activin A
Immunoenzyme Techniques
Radioimmunoassay
Case-Control Studies
Odds Ratio
Regression Analysis
Confidence Intervals
Control Groups

Keywords

  • Activin A
  • Amniocentesis
  • Amniotic fluid
  • Corticotropin-releasing factor
  • Fetal death

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Increased midtrimester amniotic fluid activin A : A risk factor for subsequent fetal death. / Petraglia, F.; Gomez, R.; Luisi, S.; Florio, P.; Tolosa, Jorge; Stomati, M.; Romero, R.

In: American Journal of Obstetrics and Gynecology, Vol. 180, No. 1 I, 1999, p. 194-197.

Research output: Contribution to journalArticle

Petraglia, F. ; Gomez, R. ; Luisi, S. ; Florio, P. ; Tolosa, Jorge ; Stomati, M. ; Romero, R. / Increased midtrimester amniotic fluid activin A : A risk factor for subsequent fetal death. In: American Journal of Obstetrics and Gynecology. 1999 ; Vol. 180, No. 1 I. pp. 194-197.
@article{e6b3faa7958746fb90f7db15ff6a40c1,
title = "Increased midtrimester amniotic fluid activin A: A risk factor for subsequent fetal death",
abstract = "OBJECTIVE: The objective of this study was to determine whether concentrations of activin A and corticotropin-releasing factor in amniotic fluid can identify patients at risk of fetal death. STUDY DESIGN: A retrospective case-control study of women who have had a midtrimester amniocentesis was designed. Case subjects consisted of patients who had a spontaneous fetal death after the procedure, whereas the control group consisted of patients who had a normal pregnancy outcome after midtrimester amniocentesis. Dimeric activin A was measured by a specific 2-site enzyme immunoassay, and corticotropin-releasing factor was measured by a specific and sensitive radioimmunoassay after acidic extraction. Statistical analysis was performed with Mann-Whitney U test, Fisher's exact test, and χ2 tests and regression analysis. RESULTS: First, activin A was detectable in all amniotic fluid samples. Second, the concentration of activin A in amniotic fluid increased with advancing gestational age. Third, patients who subsequently had a fetal death had a higher median concentration of activin A than those with a normal pregnancy outcome (P <.01). Fourth, an amniotic fluid concentration of activin A greater than the 95th confidence interval for gestational age was found in 40{\%} of patients who subsequently had a fetal death (odds ratio: 21.6; P <.005). Finally, the median concentration of corticotropin-releasing factor in amniotic fluid was not different in case subjects and control subjects. CONCLUSIONS: An elevated concentration of activin A in amniotic fluid identifies women at risk of fetal death.",
keywords = "Activin A, Amniocentesis, Amniotic fluid, Corticotropin-releasing factor, Fetal death",
author = "F. Petraglia and R. Gomez and S. Luisi and P. Florio and Jorge Tolosa and M. Stomati and R. Romero",
year = "1999",
doi = "10.1016/S0002-9378(99)70174-2",
language = "English (US)",
volume = "180",
pages = "194--197",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1 I",

}

TY - JOUR

T1 - Increased midtrimester amniotic fluid activin A

T2 - A risk factor for subsequent fetal death

AU - Petraglia, F.

AU - Gomez, R.

AU - Luisi, S.

AU - Florio, P.

AU - Tolosa, Jorge

AU - Stomati, M.

AU - Romero, R.

PY - 1999

Y1 - 1999

N2 - OBJECTIVE: The objective of this study was to determine whether concentrations of activin A and corticotropin-releasing factor in amniotic fluid can identify patients at risk of fetal death. STUDY DESIGN: A retrospective case-control study of women who have had a midtrimester amniocentesis was designed. Case subjects consisted of patients who had a spontaneous fetal death after the procedure, whereas the control group consisted of patients who had a normal pregnancy outcome after midtrimester amniocentesis. Dimeric activin A was measured by a specific 2-site enzyme immunoassay, and corticotropin-releasing factor was measured by a specific and sensitive radioimmunoassay after acidic extraction. Statistical analysis was performed with Mann-Whitney U test, Fisher's exact test, and χ2 tests and regression analysis. RESULTS: First, activin A was detectable in all amniotic fluid samples. Second, the concentration of activin A in amniotic fluid increased with advancing gestational age. Third, patients who subsequently had a fetal death had a higher median concentration of activin A than those with a normal pregnancy outcome (P <.01). Fourth, an amniotic fluid concentration of activin A greater than the 95th confidence interval for gestational age was found in 40% of patients who subsequently had a fetal death (odds ratio: 21.6; P <.005). Finally, the median concentration of corticotropin-releasing factor in amniotic fluid was not different in case subjects and control subjects. CONCLUSIONS: An elevated concentration of activin A in amniotic fluid identifies women at risk of fetal death.

AB - OBJECTIVE: The objective of this study was to determine whether concentrations of activin A and corticotropin-releasing factor in amniotic fluid can identify patients at risk of fetal death. STUDY DESIGN: A retrospective case-control study of women who have had a midtrimester amniocentesis was designed. Case subjects consisted of patients who had a spontaneous fetal death after the procedure, whereas the control group consisted of patients who had a normal pregnancy outcome after midtrimester amniocentesis. Dimeric activin A was measured by a specific 2-site enzyme immunoassay, and corticotropin-releasing factor was measured by a specific and sensitive radioimmunoassay after acidic extraction. Statistical analysis was performed with Mann-Whitney U test, Fisher's exact test, and χ2 tests and regression analysis. RESULTS: First, activin A was detectable in all amniotic fluid samples. Second, the concentration of activin A in amniotic fluid increased with advancing gestational age. Third, patients who subsequently had a fetal death had a higher median concentration of activin A than those with a normal pregnancy outcome (P <.01). Fourth, an amniotic fluid concentration of activin A greater than the 95th confidence interval for gestational age was found in 40% of patients who subsequently had a fetal death (odds ratio: 21.6; P <.005). Finally, the median concentration of corticotropin-releasing factor in amniotic fluid was not different in case subjects and control subjects. CONCLUSIONS: An elevated concentration of activin A in amniotic fluid identifies women at risk of fetal death.

KW - Activin A

KW - Amniocentesis

KW - Amniotic fluid

KW - Corticotropin-releasing factor

KW - Fetal death

UR - http://www.scopus.com/inward/record.url?scp=0033030118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033030118&partnerID=8YFLogxK

U2 - 10.1016/S0002-9378(99)70174-2

DO - 10.1016/S0002-9378(99)70174-2

M3 - Article

VL - 180

SP - 194

EP - 197

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1 I

ER -